Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.

Durand-Réville TF, Guler S, Comita-Prevoir J, Chen B, Bifulco N, Huynh H, Lahiri S, Shapiro AB, McLeod SM, Carter NM, Moussa SH, Velez-Vega C, Olivier NB, McLaughlin R, Gao N, Thresher J, Palmer T, Andrews B, Giacobbe RA, Newman JV, Ehmann DE, de Jonge B, O'Donnell J, Mueller JP, Tommasi RA, Miller AA.

Nat Microbiol. 2017 Jun 30;2:17104. doi: 10.1038/nmicrobiol.2017.104.

PMID:
28665414
2.

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.

Hagel M, Miduturu C, Sheets M, Rubin N, Weng W, Stransky N, Bifulco N, Kim JL, Hodous B, Brooijmans N, Shutes A, Winter C, Lengauer C, Kohl NE, Guzi T.

Cancer Discov. 2015 Apr;5(4):424-37. doi: 10.1158/2159-8290.CD-14-1029. Epub 2015 Mar 16.

3.

Substituted indanylacetic acids as PPAR-alpha-gamma activators.

Lowe DB, Bifulco N, Bullock WH, Claus T, Coish P, Dai M, Dela Cruz FE, Dickson D, Fan D, Hoover-Litty H, Li T, Ma X, Mannelly G, Monahan MK, Muegge I, O'Connor S, Rodriguez M, Shelekhin T, Stolle A, Sweet L, Wang M, Wang Y, Zhang C, Zhang HJ, Zhang M, Zhao K, Zhao Q, Zhu J, Zhu L, Tsutsumi M.

Bioorg Med Chem Lett. 2006 Jan 15;16(2):297-301. Epub 2005 Nov 3.

PMID:
16275080
4.

Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors.

Kazmierski W, Bifulco N, Yang H, Boone L, DeAnda F, Watson C, Kenakin T.

Bioorg Med Chem. 2003 Jul 3;11(13):2663-76. Review. Erratum in: Bioorg Med Chem. 2003 Sep 1;11(18):4155.

PMID:
12788340
5.

The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 2: hydroxyindole derivatives.

Milkiewicz KL, Marsilje TH, Woodworth RP Jr, Bifulco N Jr, Hangauer MJ, Hangauer DG.

Bioorg Med Chem Lett. 2000 Mar 6;10(5):483-6.

PMID:
10743953

Supplemental Content

Loading ...
Support Center